[1] 国家卫生计生委合理用药专家委员会, 中国药师协会. 冠心病合理用药指南[J].中国医学前沿杂志:电子版, 2016, 8(6):19-108.
[2] 王锁儿,张俊义,王新亮.NPY的研究现状及进展[J].内蒙古医学杂志,2010,42(6):679-681+755.
[3] 谢丹丹,吕佩佳,陈杰彬,等. 慢性肾脏病患者神经肽Y与营养状态和心血管事件的相关性[J].实用医学杂志,2017,33(7):1133-1137.
[4] 胡赛玲, 陈然, 龙骁. 神经肽Y在常见疾病中的研究进展[J].医学综述, 2018,24(4):667-671.
[5] 王瑞英,李素梅,李和平. 老年冠心病患者血浆神经肽Y浓度观察[J].中国心血管杂志,2000,5(4):196-197.
[6] 张学娇, 阿拉坦高勒. 神经肽Y与疾病关系研究新进展[J].绿色科技, 2013(7):316-318.
[7] 雷静,钟巧青,Robina Matyal,等. 神经肽Y与心血管疾病的研究进展[J].国际心血管病杂志,2014,41(5):311-314.
[8] 胡春燕, 李英文. 神经肽Y(NPY)的生理功能研究进展[J].生物学杂志, 2011, 28(2):66-68.
[9] 苏伟青, 李树裕, 余泽琪, 等. 血浆神经肽Y、神经降压素水平变化与急性心肌梗死的相性研究[J].宁夏医学杂志, 2006, 28(2):101-103.
[10] Shanks J, Herring N. Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides[J].Am J Physiol Regul Integr Comp Physiol,2013, 305(12):R1411-R1420.
[11] Matyal R, Sakamuri S, Wang A,et al. Local infiltration of neuropeptide Y as a potential therapeutic agent against apoptosis and fibrosis in a swine model of hypercholesterolemia and chronic myocardial ischemia.[J].Eur J Pharmacol,2013, 718(1-3):261-270.
[12] Coelho EF, Ferrari MF, Maximino JR, et al. Change in the expression of NPY receptor subtypes Y1 and Y2 in central and peripheral neurons related to the control of blood pressure in rats following experimental hypertension[J].Neuropeptides,2004, 38(2-3):77. |
2019, Vol. 36 
